Bikanta
Bikanta tried to use tiny fluorescent diamonds as imaging probes to spot cancer earlier. It went through Y Combinator in 2014 and is no longer operating.
Overview
Bikanta developed fluorescent nanodiamond probes for background-free optical imaging, aiming to improve the signal of medical imaging and diagnostics by up to 100-fold over conventional fluorescence according to its YC profile. Nanodiamonds are bright, photostable and non-toxic and can be functionalised to bind cancer targets. The company is listed as inactive in the YC directory and its website was offline when checked on 2026-09-10; no clinical product was launched. Recorded here as part of the complete map of YC companies that took on cancer.
Funding
All startupsPages like this
not linked directly; found by shared links- CompanyNearWave
Shares Optical & fluorescence imaging, Y Combinator and the tag yc.
- CompanyAluna
Shares Y Combinator and the tag yc.
- CompanyLiyfe
Shares Y Combinator and the tag yc.
- CompanyMednet (theMednet)
Shares Y Combinator and the tag yc.
- CompanyREPROSENT
Shares Y Combinator and the tag yc.
- CompanyAlixia
Shares Y Combinator and the tag yc.
- CompanyVelorum Therapeutics
Shares Y Combinator and the tag yc.
- CompanyDelee
Shares Y Combinator and the tag yc.